Hims & Hers Halts Sales of Compounded Obesity Drug Amid Regulatory Scrutiny Hims & Hers Health, Inc. has ceased the sale of …
For complains, abuse, advertising contact: [email protected]
Tag:
pharmaceuticals
-
-
New Analysis Challenges Perceptions of Statin Side Effects A significant number of individuals who stand to benefit from cholesterol-lowering statin medications are …
-
New Regulations Demand Transparency from Pharmacy Benefit Managers Washington D.C. – A landmark proposed rule issued by the Department of Labor on …
-
The biopharmaceutical landscape is experiencing a dynamic shift in leadership, with key appointments signaling strategic realignments and growth initiatives. Today, Magnet Biomedicine …
-
Nearly 40% of U.S. adults are now considered obese, a figure that continues to climb despite decades of public health campaigns. But …
-
Novo Nordisk’s Wegovy Pill: Price War Ignites in Weight Loss Market A significant shift is underway in the rapidly expanding weight loss …
-
The Food and Drug Administration (FDA) has mandated an update to the warning label for Depo-Provera, Pfizer’s widely used birth control injection, …
-
Washington D.C. – A significant shift in access to groundbreaking obesity treatments is on the horizon, following the White House’s announcement of …
-
China’s Ascendance in Global Pharmaceuticals: A New Era of Dominance The global pharmaceutical landscape is undergoing a seismic shift, with China rapidly …
-
Trump Administration Announces Medicare Drug Price Cuts Under Inflation Reduction Act WASHINGTON – In a surprising turn of events, the Trump administration …